Propranolol therapy

Scribner, M. D.

doi:10.1001/archderm.113.9.1303b

Cited by 6 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…One survey examining dermatologic conditions and skin care needs of 68 subjects aged 50 to 91 years (mean age of 74 years) found that two-thirds of the subjects reported one or more specific complaints about their skin with pruritus being the most common complaint, affecting at least 29% of the subjects [3]. Another study involving 1,556 patients from a skilled-nursing facility reported that the two most common dermatologic conditions were xerosis and pruritus, with nearly two-thirds of patients reporting pruritus as a major complaint [4]. Thus, pruritus has a high prevalence within the elderly population.…”

Section: Prevalence Of Pruritus and It’s Impact On Quality Of Lifementioning

confidence: 99%

Advanced aging skin and itch: addressing an unmet need

2013

View full text Add to dashboard Cite

Itch is the most common skin disorder in the elderly and frequently diminishes quality of life in this population. The high prevalence of pruritus in elderly patients is attributed in part to the decline in the normal physiology of the advanced aging skin, and reflects poor hydration, impaired skin barrier, and altered neural function, all ultimately contributing to inflammation and pruritus. As the elderly population continues to grow, practitioners need to be aware of how to evaluate and manage pruritus, recognizing the common conditions contributing to itch in elderly patients as well as the challenges of treatment in this group. Ultimately, management of pruritus will require an individually tailored approach that is guided by a patient's general health, severity of symptoms, and the potential adverse effects of itch therapies.

show abstract

Section: Prevalence Of Pruritus and It’s Impact On Quality Of Lifementioning

confidence: 99%

Advanced aging skin and itch: addressing an unmet need

2013

View full text Add to dashboard Cite

show abstract

“…Plus rarement, peut apparaître une éruption acnéiforme [29], un éry thème polymorphe [14,29], une alopécie diffuse [29,38] ou une éruption évoquant un pityriasis rubra pilaire [12]. Exceptionnellement, les bêta-bloquants déclenchent un syndrome de Lyell [44], une hyperpigmentation généralisée (de type Addison sans patho logie hormonale) ou un purpura thrombopénique [29], Le délai de ces effets secondaires varie de quelques jours à quelques mois.…”

Section: Effets Secondaires En Relation Avec L'action Pharmacologiqueunclassified

Revue: A propos des bêta-bloquants en dermatologie

Clerens¹,

Guilmotbruneau²,

Defresne³

et al. 1981

Dermatology

View full text Add to dashboard Cite

The authors present a survey of the side effects of beta-blocking agents. Practolol has been linked with a lupus syndrome caracterized by biological abnormalities and eventually clinical signs; later on, other beta-blocking agents have been able to induce such manifestations. Thus, all beta-blocking agents proved hazardous and they must be prescribed with extreme caution in patients with immunological imbalance. Furthermore, pruritus and lichenoid or psoriasiform dermatitis have been documented. This must be kept in mind in the presence of any unspecific rash in elderly patients.

show abstract